BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19484476)

  • 1. Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women.
    Huo X; Lu C; Huang X; Hu Z; Jin G; Ma H; Wang X; Qin J; Wang X; Shen H; Tang J
    J Cancer Res Clin Oncol; 2009 Nov; 135(11):1569-75. PubMed ID: 19484476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Evaluation of ZNF350 Missense Genetic Variants Associated with Breast Cancer Susceptibility.
    Zhang N; Lu Y; Liu X; Yu D; Lv Z; Yang M
    DNA Cell Biol; 2018 Jun; 37(6):543-550. PubMed ID: 29653063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families.
    Guénard F; Labrie Y; Ouellette G; Joly Beauparlant C; Simard J; ; Durocher F
    J Hum Genet; 2008; 53(7):579. PubMed ID: 18414782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
    Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
    Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First evidence for the contribution of the genetic variations of BRCA1-interacting protein 1 (BRIP1) to the genetic susceptibility of cervical cancer.
    Ma XD; Cai GQ; Zou W; Huang YH; Zhang JR; Wang DT; Chen BL
    Gene; 2013 Jul; 524(2):208-13. PubMed ID: 23644138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes.
    Sigurdson AJ; Hauptmann M; Chatterjee N; Alexander BH; Doody MM; Rutter JL; Struewing JP
    BMC Cancer; 2004 Mar; 4():9. PubMed ID: 15113441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles.
    Seal S; Thompson D; Renwick A; Elliott A; Kelly P; Barfoot R; Chagtai T; Jayatilake H; Ahmed M; Spanova K; North B; McGuffog L; Evans DG; Eccles D; ; Easton DF; Stratton MR; Rahman N
    Nat Genet; 2006 Nov; 38(11):1239-41. PubMed ID: 17033622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRIP1 variations analysis reveals their relative importance as genetic susceptibility factor for cervical cancer.
    Ma XD; Cai GQ; Zou W; Huang YH; Zhang JR; Wang DT; Chen BL
    Biochem Biophys Res Commun; 2013 Apr; 433(2):232-6. PubMed ID: 23473757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants and haplotype analyses of the ZBRK1/ZNF350 gene in high-risk non BRCA1/2 French Canadian breast and ovarian cancer families.
    Desjardins S; Belleau P; Labrie Y; Ouellette G; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Pichette R; Plante M; ; Durocher F
    Int J Cancer; 2008 Jan; 122(1):108-16. PubMed ID: 17764113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel breast cancer-associated BRIP1 (FANCJ/BACH1) germ-line mutation impairs protein stability and function.
    De Nicolo A; Tancredi M; Lombardi G; Flemma CC; Barbuti S; Di Cristofano C; Sobhian B; Bevilacqua G; Drapkin R; Caligo MA
    Clin Cancer Res; 2008 Jul; 14(14):4672-80. PubMed ID: 18628483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of ZNF350/ZBRK1 promoter variants and breast cancer susceptibility in non-BRCA1/2 French Canadian breast cancer families.
    Plourde KV; Labrie Y; Desjardins S; Belleau P; Ouellette G; Durocher F;
    J Hum Genet; 2013 Feb; 58(2):59-66. PubMed ID: 23151675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer.
    Kim H; Cho DY; Choi DH; Jung GH; Shin I; Park W; Huh SJ; Nam SJ; Lee JE; Gil WH; Kim SW
    Cancer Res Treat; 2016 Jul; 48(3):955-61. PubMed ID: 26790966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer.
    Song H; Ramus SJ; Kjaer SK; Hogdall E; Dicioccio RA; Whittemore AS; McGuire V; Hogdall C; Jacobs IJ; Easton DF; Ponder BA; Dunning AM; Gayther SA; Pharoah PD
    PLoS One; 2007 Mar; 2(3):e268. PubMed ID: 17342202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Single-Nucleotide Polymorphisms in Monoubiquitinated FANCD2-DNA Damage Repair Pathway Genes With Breast Cancer in the Chinese Population.
    Chen FY; Wang H; Li H; Hu XL; Dai X; Wang SM; Yan GJ; Jiang PL; Hu YP; Huang J; Tang LL
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818819841. PubMed ID: 30799775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.
    Easton DF; Lesueur F; Decker B; Michailidou K; Li J; Allen J; Luccarini C; Pooley KA; Shah M; Bolla MK; Wang Q; Dennis J; Ahmad J; Thompson ER; Damiola F; Pertesi M; Voegele C; Mebirouk N; Robinot N; Durand G; Forey N; Luben RN; Ahmed S; Aittomäki K; Anton-Culver H; Arndt V; ; Baynes C; Beckman MW; Benitez J; Van Den Berg D; Blot WJ; Bogdanova NV; Bojesen SE; Brenner H; Chang-Claude J; Chia KS; Choi JY; Conroy DM; Cox A; Cross SS; Czene K; Darabi H; Devilee P; Eriksson M; Fasching PA; Figueroa J; Flyger H; Fostira F; García-Closas M; Giles GG; Glendon G; González-Neira A; Guénel P; Haiman CA; Hall P; Hart SN; Hartman M; Hooning MJ; Hsiung CN; Ito H; Jakubowska A; James PA; John EM; Johnson N; Jones M; Kabisch M; Kang D; ; Kosma VM; Kristensen V; Lambrechts D; Li N; ; Lindblom A; Long J; Lophatananon A; Lubinski J; Mannermaa A; Manoukian S; Margolin S; Matsuo K; Meindl A; Mitchell G; Muir K; ; Nevelsteen I; van den Ouweland A; Peterlongo P; Phuah SY; Pylkäs K; Rowley SM; Sangrajrang S; Schmutzler RK; Shen CY; Shu XO; Southey MC; Surowy H; Swerdlow A; Teo SH; Tollenaar RA; Tomlinson I; Torres D; Truong T; Vachon C; Verhoef S; Wong-Brown M; Zheng W; Zheng Y; Nevanlinna H; Scott RJ; Andrulis IL; Wu AH; Hopper JL; Couch FJ; Winqvist R; Burwinkel B; Sawyer EJ; Schmidt MK; Rudolph A; Dörk T; Brauch H; Hamann U; Neuhausen SL; Milne RL; Fletcher O; Pharoah PD; Campbell IG; Dunning AM; Le Calvez-Kelm F; Goldgar DE; Tavtigian SV; Chenevix-Trench G
    J Med Genet; 2016 May; 53(5):298-309. PubMed ID: 26921362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four common polymorphisms of BRIP1 (rs2048718, rs4988344, rs4986764, and rs6504074) and cancer risk: evidence from 13,716 cancer patients and 15,590 cancer-free controls.
    Liu D; Zheng Y; Wang M; Deng Y; Lin S; Zhou L; Yang P; Dai C; Xu P; Hao Q; Song D; Kang H; Dai Z
    Aging (Albany NY); 2018 Feb; 10(2):266-277. PubMed ID: 29466248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CASP8, XRCC1, WRN, NF2, and BRIP1 Polymorphisms Analysis Shows Their Genetic Susceptibility for Meningioma Risk and the Association with Tumor-Related Phenotype in a Chinese Population.
    Huang G; Feng J; Hao S; Li D; Wang K; Wang L; Wu Z; Wan H; Zhang L; Zhang J
    World Neurosurg; 2018 Jun; 114():e883-e891. PubMed ID: 29581016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRIP1, a potential candidate gene in development of non-BRCA1/2 breast cancer.
    Ouhtit A; Gupta I; Shaikh Z
    Front Biosci (Elite Ed); 2016 Jan; 8(2):289-98. PubMed ID: 26709662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.